Val John Lowe
Physician in Rochester, MN
License number
Utah 181807-8905
Issued Date
Mar 8, 1990
Expiration Date
Jan 31, 2018
Category
Physician
Type
Physician/Surgeon CS (Schedule 2-5)
Address
Address
Rochester, MN
Professional information
Dr. Val J Lowe, Rochester MN - MD (Doctor of Medicine)
Specialties:
Nuclear Medicine
Address:
Mayo Clinic Radiology
200 1St St SW, Rochester 55905
(507) 284-2511 (Phone)
200 1St St SW, Rochester 55905
(507) 284-2511 (Phone)
Certifications:
Nuclear Medicine, 1993
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Mayo Clinic Radiology
200 1St St SW, Rochester 55905
The Methodist Hospital
6565 Fannin St, Houston 77030
200 1St St SW, Rochester 55905
The Methodist Hospital
6565 Fannin St, Houston 77030
Education:
Medical School
McGill University / Faculty of Medicine
L D S Hospital
Duke University Hospital
McGill University / Faculty of Medicine
L D S Hospital
Duke University Hospital
Val Lowe, Rochester MN
Work:
Mayo Medical School
200 1St St Sw, Rochester, MN 55905
200 1St St Sw, Rochester, MN 55905
Val J Lowe, Rochester MN
Specialties:
Nuclear Medicine Specialist
Address:
Mayo Clinic, Rochester, MN 55905
200 1St St Sw, Rochester, MN 55905
200 1St St Sw, Rochester, MN 55905
Peptide-Mediated Non-Covalent Delivery Of Active Agents Across The Blood-Brain Barrier
US Patent:
2012010, May 3, 2012
Filed:
Jul 14, 2010
Appl. No.:
13/383710
Inventors:
Geoffry L. Curran - Rochester MN, US
Gobinda Sarkar - Rochester MN, US
Joseph F. Poduslo - Rochester MN, US
Robert B. Jenkins - Rochester MN, US
Val J. Lowe - Rochester MN, US
Eric W. Mahlum - Rochester MN, US
Gobinda Sarkar - Rochester MN, US
Joseph F. Poduslo - Rochester MN, US
Robert B. Jenkins - Rochester MN, US
Val J. Lowe - Rochester MN, US
Eric W. Mahlum - Rochester MN, US
Assignee:
MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH - Rochester MN
International Classification:
A61K 49/00, C07K 9/00, C07K 14/00, C07K 7/08, C07K 7/06, C07K 5/10, C07K 16/00, A61P 35/00, A61K 38/08, A61K 38/10, A61P 25/00, A61P 25/08, A61P 25/16, A61P 25/28, A61P 31/18, A61K 38/07
US Classification:
424 91, 514 12, 530322, 530324, 530325, 530326, 530327, 530328, 530329, 530330, 530359, 5303913
Abstract:
The peptides described herein can function as carrier peptides. These peptides can associate with (e.g., non-covalently bind) biologically active molecules or imaging agents to transport the biologically active molecules or imaging across the blood-brain barrier. In some cases, such transport may increase the effectiveness of the biological molecules or imaging agents.
Imaging Of Meningiomas Using Phingylbenzothiazole, Stilbene, Or Biphenylalkyne Derivatives
US Patent:
2013026, Oct 10, 2013
Filed:
Oct 11, 2011
Appl. No.:
13/878689
Inventors:
Geoffrey B. Johnson - Rochester MN, US
Val J. Lowe - Rochester MN, US
Mark A. Nathan - Rochester MN, US
Joseph E. Parisi - Rochester MN, US
Val J. Lowe - Rochester MN, US
Mark A. Nathan - Rochester MN, US
Joseph E. Parisi - Rochester MN, US
International Classification:
A61K 51/04
US Classification:
424 189, 424 181, 424 165
Abstract:
Methods for detecting or ruling out a meningioma in a patient using a phenylbenzothiazole derivative or a stilbene derivative or a biphenylalkyne derivative, and a medical imaging technique such as positron emission tomography/computed tomography are disclosed. In one version of the method, the phenylbenzothiazole derivative is a compound of formula (V):